Lexaria Bioscience (LEXX) Property, Plant & Equipment (Net) Growth (5y) (2020 - 2026)
Lexaria Bioscience (LEXX) Property, Plant & Equipment (Net) Growth (5y) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
| 10 |
Lexaria Bioscience |
7.49 Mn |
1.97 Mn |
20,000.00 |
| Date | Value |
|---|
| Feb 28, 2026 |
-10.51% |
| Nov 30, 2025 |
-13.73% |
| Aug 31, 2025 |
-13.94% |
| May 31, 2025 |
-14.03% |
| Feb 28, 2025 |
-13.42% |
| Nov 30, 2024 |
-13.69% |
| Aug 31, 2024 |
-15.50% |
| May 31, 2024 |
-18.42% |
| Feb 29, 2024 |
-12.16% |
| Nov 30, 2023 |
13.61% |
| Aug 31, 2023 |
190.10% |
| May 31, 2023 |
188.23% |
| Feb 28, 2023 |
187.04% |
| Nov 30, 2022 |
183.41% |
| Aug 31, 2022 |
179.31% |
| May 31, 2022 |
179.57% |
| Aug 31, 2021 |
171.96% |
| May 31, 2021 |
172.53% |
| Feb 28, 2021 |
173.11% |
| Nov 30, 2020 |
173.81% |
